Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 164

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease: Meta-analysis: rifaximin therapy in uncomplicated diverticular disease

Open access
Bianchi, M., Festa, V., Moretti, A., Ciaco, A., Mangone, M., Tornatore, V., Dezi, A., Luchetti, R., De Pascalis, B., Papi, C., Koch, M. · 2011 · Alimentary Pharmacology & Therapeutics

Abstract

BACKGROUND: Diverticular disease of the colon is a common gastrointestinal disease. Although most patients remain asymptomatic for their whole life, about 20-25% present symptoms related to 'diverticular disease'. Several randomised trials verified efficacy of a poorly absorbed antibiotic, such as rifaximin-α (rifaximin), in soothing symptoms and preventing diverticulitis. AIM: To evaluate the long-term efficacy administration of rifaximin plus fibre supplementation vs. fibre supplementation alone, on symptoms and complications, in patient with symptomatic uncomplicated diverticular disease. METHODS: Pertinent studies were selected from the Medline, and the Cochrane Library Databases, references from published articles and reviews. Conventional meta-analysis according to DerSimonian and Laird method was used for the pooling of the results. The outcomes were 1- year complete symptom relief, and 1- year complication incidence. The rate difference (RD, with 95% CI) and the Number Needed to Treat (NNT) were used as measure of the therapeutic effect on each outcome. RESULTS: Four prospective randomised trials including 1660 patients were selected. The pooled RD for symptom relief was 29.0% (rifaximin vs. control; 95% CI 24.5-33.6%; P<0.0001; NNT=3). The pooled RD for complication rate was -1.7% in favour of rifaximin (95% CI -3.2 to -0.1%; P=0.03; NNT=59). When considering only acute diverticulitis, the pooled RD in the treatment group was -2% (95% CI -3.4 to -0.6%; P=0.0057; NNT=50). CONCLUSIONS: In symptomatic uncomplicated diverticular disease, treatment with rifaximin plus fibre supplementation is effective in obtaining symptom relief and preventing complications at 1 year.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2011.04606.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 164

Metadata

Authors
Bianchi, M., Festa, V., Moretti, A., Ciaco, A., Mangone, M., Tornatore, V., Dezi, A., Luchetti, R., De Pascalis, B., Papi, C., & Koch, M.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2011-03-02
Volume
33
Issue
8
Pages
902-910
ISSN
0269-2813 (ISSN-L)
OpenAlex
W1557515811
Cited by
164
References
2
FWCI
6.33
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease: Meta-analysis: rifaximin therapy in uncomplicated diverticular disease. https://app.cochat.ai/papers/10.1111/j.1365-2036.2011.04606.x
The paper
Bianchi, M., Festa, V., Moretti, A., Ciaco, A., Mangone, M., Tornatore, V., Dezi, A., Luchetti, R., De Pascalis, B., Papi, C., & Koch, M. (2011). Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease: Meta-analysis: rifaximin therapy in uncomplicated diverticular disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2011.04606.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.